CIK 0001513525 · Non-accelerated filer<br>Smaller reporting company
Azora Therapeutics, Inc. (DE)
Sign in to watch- Ticker
- AZR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800667150
- Phone
- 434-422-9800
- Business address
- 16501 VENTURA BLVD, SUITE 400, ENCINO, CA, 91436
- Former names
- ADIAL PHARMACEUTICALS, INC., Adial Pharmaceuticals, L.L.C., ADial Pharmaceuticals, L.L.C.
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Other events
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Other events
- 8-K Event Unregistered share sale · Other events
- 8-K Event Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change · Shareholder vote results
- 8-K Event Material agreement
- 4 Open-market sale Chief Medical Officer sold 350,000 shares at $1.21 ($423,500)
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Other events
- DEFA14A Proxy Proxy Materials
- 8-K Event Other events
- DEF 14A Proxy Proxy Statement
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- UPLOAD Other SEC-generated Letter
Page 21 of 30 · 581 filings